Related references
Note: Only part of the references are listed.Role of Vitamin E for Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes: A Randomized Controlled Trial
Fernando Bril et al.
DIABETES CARE (2019)
Functionalized cerium oxide nanoparticles mitigate the oxidative stress and pro-inflammatory activity associated to the portal vein endothelium of cirrhotic rats
Jordi Ribera et al.
PLOS ONE (2019)
Cerium oxide nanoparticles: In pursuit of liver protection against doxorubicin-induced injury in rats
Heba G. Ibrahim et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
Steven J. Forrester et al.
CIRCULATION RESEARCH (2018)
Validation of a routine gas chromatography mass spectrometry method for 2-hydroxyglutarate quantification in human serum as a screening tool for detection of idh mutations
Esther Fernandez-Galan et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2018)
Lipotoxicity and the gut-liver axis in NASH pathogenesis
Fabio Marra et al.
JOURNAL OF HEPATOLOGY (2018)
Preclinical models of non-alcoholic fatty liver disease
Prasanna K. Santhekadur et al.
JOURNAL OF HEPATOLOGY (2018)
Dynamic role of the transmembrane glycoprotein CD36 (SR-B2) in cellular fatty acid uptake and utilization
Jan F. C. Glatz et al.
JOURNAL OF LIPID RESEARCH (2018)
Toxicity and tissue distribution of cerium oxide nanoparticles in rats by two different routes: single intravenous injection and single oral administration
Kwangsik Park et al.
ARCHIVES OF PHARMACAL RESEARCH (2018)
Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress
Bing-Hang Li et al.
TRANSLATIONAL RESEARCH (2017)
Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats
Nazarii Kobyliak et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions
Amedeo Lonardo et al.
DIGESTIVE AND LIVER DISEASE (2017)
Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice
Camella G. Wilson et al.
ENDOCRINOLOGY (2016)
Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis
Denise Oro et al.
JOURNAL OF HEPATOLOGY (2016)
Effects of dietary fatty acids and cholesterol excess on liver injury: A lipidomic approach
Gaetano Serviddio et al.
REDOX BIOLOGY (2016)
Cerium oxide nanoparticles alleviate oxidative stress and decreases Nrf-2/HO-1 in D-GALN/LPS induced hepatotoxicity
Reem M. Hashem et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Glutathione replenishing potential of CeO2 nanoparticles in human breast and fibrosarcoma cells
Mohd Javed Akhtar et al.
JOURNAL OF COLLOID AND INTERFACE SCIENCE (2015)
Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats
Qing-Rong Pan et al.
NUTRITION RESEARCH (2015)
Uncoupling protein-2 is an antioxidant that is up-regulated in the enamel organ of fluoride-treated rats
Maiko Suzuki et al.
CONNECTIVE TISSUE RESEARCH (2014)
CXCL10 plays a key role as an inflammatory mediator and a non-invasive biomarker of non-alcoholic steatohepatitis
Xiang Zhang et al.
JOURNAL OF HEPATOLOGY (2014)
Nanoceria protects from alterations in oxidative metabolism and calcium overloads induced by TNFα and cycloheximide in U937 cells: pharmacological potential of nanoparticles
David Gonzalez-Flores et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
Genotoxicity analysis of cerium oxide micro and nanoparticles in Wistar rats after 28 days of repeated oral administration
Monika Kumari et al.
MUTAGENESIS (2014)
Gene expression profiles reveal distinct immunological responses of cobalt and cerium dioxide nanoparticles in two in vitro lung epithelial cell models
Sandra Verstraelen et al.
TOXICOLOGY LETTERS (2014)
Experimental models of non-alcoholic fatty liver disease in rats
Otto Kucera et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Absence of Ce3+ Sites in Chemically Active Colloidal Ceria Nanoparticles
Jean-Daniel Cafun et al.
ACS NANO (2013)
Bio-distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice
Suzanne Marie Hirst et al.
ENVIRONMENTAL TOXICOLOGY (2013)
Docosahexaenoic acid for the treatment of fatty liver: Randomised controlled trial in children
V. Nobili et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2013)
Caspase-1 as a Central Regulator of High Fat Diet-Induced Non-Alcoholic Steatohepatitis
Laura J. Dixon et al.
PLOS ONE (2013)
Inhibition of NF-κB Activation by 4-Hydroxynonenal Contributes to Liver Injury in a Mouse Model of Alcoholic Liver Disease
Xiaobing Dou et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Ceria Nanoparticles that can Protect against Ischemic Stroke
Chi Kyung Kim et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Cerium oxide nanoparticles scavenge nitric oxide radical (•NO)
Janet M. Dowding et al.
CHEMICAL COMMUNICATIONS (2012)
The epidemiology, pathogenesis and histopathology of fatty liver disease
Adam P. Levene et al.
HISTOPATHOLOGY (2012)
Prevention of Fibrosis Progression in CCl4-Treated Rats: Role of the Hepatic Endocannabinoid and Apelin Systems
Vedrana Reichenbach et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Combined cytotoxic and anti-invasive properties of redox-active nanoparticles in tumor-stroma interactions
Lirija Alili et al.
BIOMATERIALS (2011)
Free Radical Lipid Peroxidation: Mechanisms and Analysis
Huiyong Yin et al.
CHEMICAL REVIEWS (2011)
Antioxidant Therapy: Current Status and Future Prospects
O. Firuzi et al.
CURRENT MEDICINAL CHEMISTRY (2011)
Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes
Pedro Melgar-Lesmes et al.
GUT (2011)
Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
Judith Ertle et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Mitochondrial Carnitine Palmitoyltransferase 1a (CPT1a) Is Part of an Outer Membrane Fatty Acid Transfer Complex
Kwangwon Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Problems and challenges in the development and validation of human cell-based assays to determine nanoparticle-induced immunomodulatory effects
Gertie J. Oostingh et al.
PARTICLE AND FIBRE TOXICOLOGY (2011)
Oxidation of Hepatic Carnitine Palmitoyl Transferase-I (CPT-I) Impairs Fatty Acid Beta-Oxidation in Rats Fed a Methionine-Choline Deficient Diet
Gaetano Serviddio et al.
PLOS ONE (2011)
A Silybin-Phospholipid Complex Prevents Mitochondrial Dysfunction in a Rodent Model of Nonalcoholic Steatohepatitis
Gaetano Serviddio et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Effects of Dietary Polyunsaturated Fatty Acids on Mitochondria
S. Rohrbach
CURRENT PHARMACEUTICAL DESIGN (2009)
Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension
B. Lavina et al.
GUT (2009)
Nonalcoholic fatty liver disease in type 2 diabetes mellitus
Kenneth Cusi
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2009)
Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance
Muhammad A. Abdul-Ghani et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Fenton-like reaction catalyzed by the rare earth inner transition metal cerium
Eric G. Heckert et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2008)
The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity
ZhengZheng Li et al.
HEPATOLOGY (2008)
N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis
January N. Baumgardner et al.
JOURNAL OF NUTRITION (2008)
A lipidomic analysis of nonalcoholic fatty liver disease
Puneet Puri et al.
HEPATOLOGY (2007)
Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model
Reeta Vetelaeinen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy
Jianli Niu et al.
CARDIOVASCULAR RESEARCH (2007)
Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles
Cassandra Korsvik et al.
CHEMICAL COMMUNICATIONS (2007)
Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides
Junping Chen et al.
NATURE NANOTECHNOLOGY (2006)
Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis
H Malhi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension
M Hernández-Guerra et al.
HEPATOLOGY (2006)
Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it
K Begriche et al.
MITOCHONDRION (2006)
The effects of polyunsaturated:saturated fatty acids ratios and peroxidisability index values of dietary fats on serum lipid profiles and hepatic enzyme activities in rats
MJ Kang et al.
BRITISH JOURNAL OF NUTRITION (2005)
Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis
E Albano et al.
GUT (2005)
The chemoprotective agent N-acetylcysteine blocks cisplatin-induced apoptosis through caspase signaling pathway
YJ Wu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Nonalcoholic steatohepatitis: Histologic features and clinical correlations with 30 blinded biopsy specimens
EM Brunt et al.
HUMAN PATHOLOGY (2004)
4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells
E Zamara et al.
JOURNAL OF HEPATOLOGY (2004)
Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease
T Roskams et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Non-alcoholic steatohepatitis: What is it, and why is it important in the Asia-Pacific region?
GC Farrell
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
Rodent nutritional model of non-alcoholic steatohepatitis: Species, strain and sex difference studies
R Kirsch et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis
J George et al.
JOURNAL OF HEPATOLOGY (2003)
Relationship between tissue lipid peroxidation and peroxidizability index after alpha-linolenic, eicosapentaenoic, or docosahexaenoic acid intake in rats
M Saito et al.
BRITISH JOURNAL OF NUTRITION (2003)
Pathogenesis of steatohepatitis
CP Day
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2002)
PPARs: transcriptional effectors of fatty acids and their derivatives
AK Hihi et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Medical progress - Nonalcoholic fatty liver disease
P Angulo
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Fatty acid regulation of gene expression
PA Grimaldi
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2001)
LDL and HDL oxidation and fatty acid composition in vegetarians
A Nagyová et al.
ANNALS OF NUTRITION AND METABOLISM (2001)
Share Paper
